Literature DB >> 20658240

Functional genetic polymorphisms in interleukin-12B gene in association with systemic lupus erythematosus.

Lyuba D Miteva1, Irena M Manolova, Mariana G Ivanova, Rasho K Rashkov, Rumen M Stoilov, Maya V Gulubova, Spaska A Stanilova.   

Abstract

Genetic polymorphisms in cytokine genes, which influence gene expression, may have an important impact on SLE susceptibility and severity. The aim of this study was to examine the possible influence of two functional polymorphisms in cis-regulatory regions of IL12B gene in the susceptibility and clinical symptoms of SLE in Bulgarian patients. Female SLE patients (n = 141) and 124 healthy women were included in the study. Genotyping for the IL12B A/C polymorphism in 3'UTR was performed by restriction fragment length polymorphisms PCR assay and for the IL12Bpro polymorphism by allele-specific PCR. Genotype-22 of IL12Bpro polymorphism was overrepresented among women with SLE (28 vs. 17%; OR = 1.875; 95% CI: 1.037 ÷ 3.390; P = 0.037). Respectively, a higher frequency of allele-2 was found in patients than in controls (51% vs. 40%; OR = 1.566; 95% CI: 1.110 ÷ 2.210; P = 0.011). Also, we found significantly elevated frequency of genotype-22 of IL12Bpro polymorphism among SLE patients who were simultaneously carrier of genotype-AA of SNP in 3'UTR. Women with both homozygous genotypes, genotype-AA of SNP in 3'UTR and genotype-22 of IL12Bpro polymorphism, had a 2.1-fold significantly elevated risk for SLE development. The carrying of genotype-11 of IL12Bpro polymorphism was positively associated with hematological and neuropsychiatric manifestations of SLE. We have provided evidence that the IL12Bpro polymorphism was associated with SLE development among Bulgarian women. Although a strong individual effect of SNP in 3'UTR of IL12B was not detected, we found that genotype-22 of IL12Bpro was predominantly combined with genotype-AA of SNP in 3'UTR among SLE patients and this combination elevates the risk of SLE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658240     DOI: 10.1007/s00296-010-1547-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Functional haplotypes of IL-12B are associated with childhood atopic asthma.

Authors:  Tomomitsu Hirota; Yoichi Suzuki; Koichi Hasegawa; Kazuhiko Obara; Akira Matsuda; Mitsuteru Akahoshi; Kazuko Nakashima; Lei Cheng; Naomi Takahashi; Makiko Shimizu; Satoru Doi; Kimie Fujita; Tadao Enomoto; Motohiro Ebisawa; Shigemi Yoshihara; Yusuke Nakamura; Fumio Kishi; Taro Shirakawa; Mayumi Tamari
Journal:  J Allergy Clin Immunol       Date:  2005-08-08       Impact factor: 10.793

2.  Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus.

Authors:  E Sánchez; S Morales; L Paco; M A López-Nevot; C Hidalgo; J Jiménez-Alonso; B Torres; M A González-Gay; J L Callejas; N Ortego-Centeno; J Sánchez-Roman; M F González-Escribano; J Martín
Journal:  Rheumatology (Oxford)       Date:  2005-06-07       Impact factor: 7.580

3.  Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele.

Authors:  G Morahan; D Huang; S I Ymer; M R Cancilla; K Stephen; P Dabadghao; G Werther; B D Tait; L C Harrison; P G Colman
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

4.  Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease.

Authors:  A Zwiers; D Seegers; R Heijmans; A Koch; J Hampe; S Nikolaus; A S Peña; S Schreiber; G Bouma
Journal:  Genes Immun       Date:  2004-12       Impact factor: 2.676

5.  Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype.

Authors:  J Müller-Berghaus; K Kern; A Paschen; X D Nguyen; H Klüter; G Morahan; D Schadendorf
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

6.  Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients.

Authors:  Xinfang Huang; Jing Hua; Nan Shen; Shunle Chen
Journal:  Mod Rheumatol       Date:  2007-06-20       Impact factor: 3.023

7.  Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

Authors:  Chun Kwok Wong; Lydia Choi Wan Lit; Lai Shan Tam; Edmund Kwok Ming Li; Purple Tsz Yan Wong; Christopher Wai Kei Lam
Journal:  Clin Immunol       Date:  2008-03-25       Impact factor: 3.969

Review 8.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

9.  IL-12Bpro and GSTP1 polymorphisms in association with silicosis.

Authors:  S Stanilova; L Miteva; G Prakova
Journal:  Tissue Antigens       Date:  2007-12-13

10.  IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study.

Authors:  Lorenza Nisticò; Gabriele Giorgi; Mara Giordano; Andrea Galgani; Antonio Petrone; Sandra D'Alfonso; Massimo Federici; Umberto Di Mario; Paolo Pozzilli; Raffaella Buzzetti; Isabella Cascino
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

View more
  10 in total

1.  Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2011-08-27       Impact factor: 3.641

Review 2.  Bulgarian rheumatology: science and practice in a cost-constrained environment.

Authors:  Tsvetoslav Georgiev; Rumen Stoilov
Journal:  Rheumatol Int       Date:  2018-11-09       Impact factor: 2.631

3.  Genetic variations in the IL-12B gene in association with IL-23 and IL-12p40 serum levels in ankylosing spondylitis.

Authors:  Mariana Ivanova; Irena Manolova; Lyuba Miteva; Rada Gancheva; Rumen Stoilov; Spaska Stanilova
Journal:  Rheumatol Int       Date:  2018-11-15       Impact factor: 2.631

Review 4.  IL-12 and IL-23/Th17 axis in systemic lupus erythematosus.

Authors:  Maddalena Larosa; Margherita Zen; Mariele Gatto; Diogo Jesus; Elisabetta Zanatta; Luca Iaccarino; Luis Inês; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-21

5.  Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population.

Authors:  Yu-Huei Liu; Ching-Chu Chen; Li-Ling Liao; Lei Wan; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2012-11-19       Impact factor: 8.410

Review 6.  U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue diseasePart I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease.

Authors:  Agnieszka Paradowska-Gorycka
Journal:  Reumatologia       Date:  2015-05-18

7.  Interferon Genes Are Influenced by 17β-Estradiol in SLE.

Authors:  Ram P Singh; Bevra H Hahn; David S Bischoff
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

8.  Association between interleukin 12B and interleukin 23R gene polymorphisms and systemic lupus erythematosus: a meta-analysis.

Authors:  Jae Hyun Jung; Ji Hyun Lim; Gwan Gyu Song; Bo Young Kim
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

9.  Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Ram P Singh; Bevra H Hahn; David S Bischoff
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

10.  Gene-gene interaction and functional impact of polymorphisms on innate immune genes in controlling Plasmodium falciparum blood infection level.

Authors:  Madhumita Basu; Tania Das; Alip Ghosh; Subhadipa Majumder; Ardhendu Kumar Maji; Sumana Datta Kanjilal; Indranil Mukhopadhyay; Susanta Roychowdhury; Soma Banerjee; Sanghamitra Sengupta
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.